Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$73.27 - $83.09 $75,101 - $85,167
-1,025 Reduced 2.88%
34,552 $2.8 Million
Q3 2023

Nov 08, 2023

BUY
$73.94 - $80.67 $219,453 - $239,428
2,968 Added 9.1%
35,577 $2.67 Million
Q2 2023

Jul 20, 2023

BUY
$76.01 - $86.7 $21,358 - $24,362
281 Added 0.87%
32,609 $2.51 Million
Q1 2023

May 02, 2023

BUY
$77.31 - $88.08 $31,542 - $35,936
408 Added 1.28%
32,328 $2.68 Million
Q4 2022

Feb 08, 2023

SELL
$62.32 - $89.47 $830,227 - $1.19 Million
-13,322 Reduced 29.45%
31,920 $2.74 Million
Q3 2022

Nov 04, 2022

BUY
$59.54 - $68.01 $24,590 - $28,088
413 Added 0.92%
45,242 $2.79 Million
Q2 2022

Aug 03, 2022

BUY
$57.72 - $65.01 $26,378 - $29,709
457 Added 1.03%
44,829 $2.77 Million
Q1 2022

May 03, 2022

BUY
$57.92 - $72.58 $708,535 - $887,871
12,233 Added 38.06%
44,372 $2.64 Million
Q4 2021

Feb 04, 2022

BUY
$64.88 - $73.64 $155,841 - $176,883
2,402 Added 8.08%
32,139 $2.33 Million
Q3 2021

Nov 02, 2021

BUY
$67.69 - $73.03 $36,891 - $39,801
545 Added 1.87%
29,737 $2.08 Million
Q2 2021

Aug 03, 2021

BUY
$63.47 - $69.35 $309,289 - $337,942
4,873 Added 20.04%
29,192 $2.01 Million
Q1 2021

May 03, 2021

BUY
$60.0 - $68.46 $253,740 - $289,517
4,229 Added 21.05%
24,319 $1.57 Million
Q4 2020

Feb 03, 2021

SELL
$56.65 - $64.55 $358,707 - $408,730
-6,332 Reduced 23.96%
20,090 $1.17 Million
Q3 2020

Nov 02, 2020

BUY
$62.1 - $78.08 $565,296 - $710,762
9,103 Added 52.56%
26,422 $1.67 Million
Q2 2020

Aug 03, 2020

BUY
$72.34 - $84.0 $38,412 - $44,604
531 Added 3.16%
17,319 $1.33 Million
Q1 2020

Apr 28, 2020

BUY
$62.63 - $80.22 $1.05 Million - $1.35 Million
16,788 New
16,788 $1.26 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Torray LLC Portfolio

Follow Torray LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.